Please assess the completion status of the following clinical trial:

Trial Title: Increased Ketorolac Administration After Cesarean Section and Its Effect on Opioid Use: a Randomized Control Trial

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: PARALLEL
- Observational Model: None
- Primary Purpose: TREATMENT
- Time Perspective: None
- Masking: TRIPLE
- Phase: PHASE3
- Number of Arms: 2.0

Eligibility Criteria:
Inclusion Criteria:~* Women presenting for care at Tufts Medical Center as an outpatient in obstetrics clinic or on Labor and Delivery.~* The subject must have had a cesarean section for any indication at Tufts Medical Center to be randomized to the study~* The subject is willing to have a phone call follow up conversation 2 weeks after their surgery.~Exclusion Criteria:~* Patients with allergy to ketorolac, NSAIDS or aspirin~* Patients with peptic ulcer disease, preexisting kidney or liver disease.~* Duramorph is not used as the anesthetic for the spinal/epidural during the cesarean section.~* Patient is hemodynamically unstable due to hemorrhage.~* Patient requires therapeutic anticoagulation in the post-operative period~* Patients with peripartum cardiomyopathy~* Provider decision to exclude patient.~* Patient diagnosis of chronic hypertension, gestational hypertension, preeclampsia, HELLP syndrome, or eclampsia~* A study subject may participate in another research study while participating in this research study.

- Gender: FEMALE
- Minimum Age: 16 Years
- Maximum Age: None
- Healthy Volunteers: t

Study Arms:
- Standard Protocol (Type: NO_INTERVENTION): Subjects randomized to the standard group will receive the standard postoperative pain protocol that is currently used at Tufts Medical Center. It includes two doses of IV Ketorolac every 6 hours as needed for postoperative pain. Ibuprofen would be ordered 6 hours following the last dose after the last study drug.
- Ketorolac Protocol (Type: EXPERIMENTAL): Subjects randomized to the Ketorolac protocol will receive the study postoperative pain protocol. This includes 6 doses of IV Ketorolac, scheduled every 6 hours. The first dose is administered in the operating room or post-operative care unit.

Based on this trial design, predict the completion outcome and termination type (if applicable).